FIELD: chemistry.
SUBSTANCE: invention relates to use of a peptide of general formula CH3CO-(D-Lys)-Lys-Arg-Arg-NH2 to prevent apoptotic death of neurons, where the peptide is introduced before brain damage within 5 days.
EFFECT: prevention of apoptotic neuron death.
1 cl, 7 dwg, 4 tbl, 5 ex
| Title | Year | Author | Number |
|---|---|---|---|
| METHOD OF ISOLATION OF HIGH-MOLECULAR PROTEIN ACTIVATION COMPLEX OF HUMAN CASPASE-2 | 2016 |
|
RU2671510C1 |
| MEDICATIONS FOR TREATING PEMPHIGUS CONTAINING ANTIBODIES TO Fas-LIGAND | 2008 |
|
RU2558260C2 |
| PREPARATIONS, CONTAINING ANTIBODIES AGAINST Fas LIGAND, FOR TREATING PEMPHIGUS | 2009 |
|
RU2556818C2 |
| APPLICATION OF PEPTIDE COMPOUND FOR APOPTOSIS INDUCTION IN A TUMOR CELL | 2022 |
|
RU2796104C1 |
| METHOD FOR INHIBITING APOPTOSIS IN MAMMALIAN CELLS AND COMPOSITION FOR IMPLEMENTATION THEREOF | 2022 |
|
RU2825455C2 |
| PEPTIDE COMPOUNDS FOR INDUCTION OF APOPTOSIS IN TUMOR CELL | 2021 |
|
RU2785794C2 |
| METHOD FOR REDUCTION OF OXIDISING INJURY (VERSIONS) | 2005 |
|
RU2376028C2 |
| APPLICATION OF (2-IMIDAZOLIN-2-YLAMINO) QUINOXALINES IN DEMENTIA AND PARKINSON'S DISEASE TREATMENT | 2003 |
|
RU2332218C2 |
| INHIBITORS OF CD95 SIGNALING PATHWAY FOR TREATMENT OF MDS | 2013 |
|
RU2652348C2 |
| METHOD FOR DISCOVERING ANTICONVULSANT ACTION OF CITICOLINE IN PENTYLENETETRAZOLE KINDLING MODEL INVOLVING MALE C57B1/6 MICE | 2014 |
|
RU2567275C1 |
